Smartphone-powered trial backs J&Jās Invokana for heart failure
pharmaphorum
NOVEMBER 15, 2021
It enrolled patients with and without type 2 diabetes and heart failure, to see whether treatment with Invokana (canagliflozin) can improve their symptoms, function and quality of life compared to placebo. billion in 2016 before the product was linked to an increased risk of lower limb amputation.
Let's personalize your content